HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyohide Fujimoto Selected Research

Polyuria

3/2022The effects of choreito on a model of nocturnal polyuria using Dahl salt-sensitive rats.
7/2020Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial.
1/2020Daily salt intake is associated with leg edema and nocturnal urinary volume in elderly men.
10/2014The impact of obstructive sleep apnea syndrome on nocturnal urine production in older men with nocturia.
5/2014Preliminary Experience with Low-dose Desmopressin Treatment and Urinary Arginine Vasopressin Concentration as a Response Predictor for Patients with Nocturia with Nocturnal Polyuria.
6/2011Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men.
2/2008Increase in 24-hour urine production/weight causes nocturnal polyuria due to impaired function of antidiuretic hormone in elderly men.
1/2007Cutoff value of urinary arginine vasopressin for nocturnal polyuria in elderly men.
7/2006Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria.
6/2005Nocturia in men with lower urinary tract symptoms is associated with both nocturnal polyuria and detrusor overactivity with positive response to ice water test.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyohide Fujimoto Research Topics

Disease

97Neoplasms (Cancer)
06/2022 - 02/2003
76Prostatic Neoplasms (Prostate Cancer)
09/2022 - 06/2003
48Urinary Bladder Neoplasms (Bladder Cancer)
06/2021 - 02/2004
40Carcinoma (Carcinomatosis)
07/2022 - 02/2003
24Non-Muscle Invasive Bladder Neoplasms
07/2022 - 01/2010
22Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 02/2003
19Neoplasm Metastasis (Metastasis)
01/2022 - 06/2003
11Nocturia
07/2022 - 06/2005
10Polyuria
03/2022 - 06/2005
9Lower Urinary Tract Symptoms
01/2022 - 06/2005
7Overactive Urinary Bladder (Overactive Bladder)
01/2022 - 12/2009
7Adenocarcinoma
12/2020 - 06/2009
6Inflammation (Inflammations)
06/2022 - 09/2009
6Carcinogenesis
12/2020 - 07/2008
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2020 - 07/2003
4Carcinoma in Situ
05/2022 - 01/2010
4Hypoxia (Hypoxemia)
01/2022 - 03/2011
4Infections
08/2021 - 09/2009
4Pain (Aches)
01/2021 - 12/2005
4Margins of Excision
10/2019 - 11/2012
4Thrombosis (Thrombus)
01/2018 - 05/2008
4Pheochromocytoma
06/2013 - 12/2004
3Urologic Neoplasms (Urological Cancer)
04/2022 - 05/2020
3Lymphatic Metastasis
01/2022 - 02/2004
3Edema (Dropsy)
01/2022 - 06/2011
3Hemorrhage
01/2021 - 03/2002
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
12/2009 - 11/2003
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
09/2022 - 12/2009
2Disease Progression
06/2022 - 01/2021
2Erectile Dysfunction
02/2022 - 11/2002
2Hypertension (High Blood Pressure)
02/2022 - 02/2016
2Neurogenic Urinary Bladder (Bladder, Neurogenic)
01/2022 - 11/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2018

Drug/Important Bio-Agent (IBA)

18AcidsIBA
01/2022 - 07/2009
17Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 06/2003
14Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2009
11Biomarkers (Surrogate Marker)IBA
09/2022 - 05/2014
11Small Interfering RNA (siRNA)IBA
05/2020 - 07/2008
10AndrogensIBA
02/2022 - 12/2003
8CreatinineIBA
07/2022 - 11/2004
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 06/2003
7NitrosaminesIBA
06/2021 - 08/2007
6Biological ProductsIBA
06/2022 - 12/2013
6CytokinesIBA
06/2022 - 03/2006
6protoporphyrin IXIBA
01/2022 - 07/2009
6GemcitabineFDA Link
01/2022 - 06/2010
6Docetaxel (Taxotere)FDA Link
01/2021 - 01/2017
6Syndecan-1 (Syndecan 1)IBA
05/2020 - 01/2010
6AntibodiesIBA
06/2019 - 12/2004
5pembrolizumabIBA
03/2022 - 01/2020
5Sunitinib (Sutent)FDA Link
09/2019 - 06/2012
5Iodine-125IBA
01/2019 - 01/2009
4Immune Checkpoint InhibitorsIBA
03/2022 - 01/2020
4Tamsulosin (Flomax)FDA LinkGeneric
01/2022 - 01/2004
4Peptides (Polypeptides)IBA
01/2021 - 03/2006
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2020 - 05/2011
4Cholinergic Antagonists (Anticholinergics)IBA
01/2020 - 04/2014
4Hormones (Hormone)IBA
01/2020 - 03/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 07/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2019 - 01/2010
4Heme Oxygenase-1IBA
03/2016 - 01/2010
4Arginine Vasopressin (Argipressin)IBA
05/2014 - 07/2006
4Androgen Antagonists (Antiandrogens)IBA
01/2013 - 01/2004
3Claudin-4IBA
06/2022 - 12/2015
3IsoflavonesIBA
06/2022 - 08/2007
3Testosterone (Sustanon)FDA Link
02/2022 - 04/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2011
3Messenger RNA (mRNA)IBA
12/2021 - 06/2019
3CollagenIBA
11/2020 - 05/2017
3Cadherins (E-Cadherin)IBA
05/2020 - 12/2004
3bicalutamide (Casodex)FDA LinkGeneric
01/2020 - 06/2003
3Adrenergic Receptors (Adrenergic Receptor)IBA
10/2019 - 12/2014
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 10/2017
3MicroRNAs (MicroRNA)IBA
09/2018 - 10/2015
3AntigensIBA
01/2018 - 07/2005
3EverolimusFDA Link
06/2017 - 08/2015
3Vasopressins (Vasopressin)IBA
10/2014 - 02/2008
3Chlormadinone Acetate (Chlormadinone)IBA
01/2013 - 05/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2022 - 04/2008
2SaltsIBA
03/2022 - 01/2020
2mirabegronIBA
01/2022 - 04/2017
2PlatinumIBA
01/2022 - 01/2020
2Adenosine Triphosphate (ATP)IBA
01/2022 - 03/2016

Therapy/Procedure

50Therapeutics
07/2022 - 02/2003
25Brachytherapy
09/2022 - 01/2009
21Drug Therapy (Chemotherapy)
01/2022 - 06/2003
19Prostatectomy (Retropubic Prostatectomy)
11/2021 - 01/2004
17Cystectomy
05/2022 - 02/2004
17Nephrectomy
08/2021 - 02/2003
15Radiotherapy
09/2022 - 06/2010
11Transurethral Resection of Bladder
01/2022 - 01/2010
10Nephroureterectomy
07/2022 - 12/2016
8Castration
03/2020 - 03/2010
7Oral Administration
06/2021 - 07/2004
5Lymph Node Excision (Lymph Node Dissection)
09/2021 - 06/2003
5Orchiectomy (Orchidectomy)
10/2013 - 07/2003
4Kidney Transplantation
01/2022 - 01/2018
3Combination Drug Therapy (Combination Chemotherapy)
07/2020 - 04/2007
3Neoadjuvant Therapy
12/2019 - 04/2018
3Aftercare (After-Treatment)
05/2018 - 07/2009